Home

Lze ignorovat Ženich Okamžik odběr krve hcc marker pravidlo Mravy Odpovědná osoba

Significance of cytoplasmic expression of telomerase reverse transcriptase  in patients with hepatocellular carcinoma undergoing liver resection
Significance of cytoplasmic expression of telomerase reverse transcriptase in patients with hepatocellular carcinoma undergoing liver resection

The sensitivity/specificity of each tumor marker for HCC was depicted. |  Download Table
The sensitivity/specificity of each tumor marker for HCC was depicted. | Download Table

Liver Cancer Tumor Markers | GeneTex
Liver Cancer Tumor Markers | GeneTex

Frontiers | Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted  Therapy
Frontiers | Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy

Liver Cancer Tumor Markers | GeneTex
Liver Cancer Tumor Markers | GeneTex

Hepatocellular carcinoma cell lines retain the genomic and transcriptomic  landscapes of primary human cancers | Scientific Reports
Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers | Scientific Reports

A novel prognostic model based on single-cell RNA sequencing data for  hepatocellular carcinoma | Cancer Cell International | Full Text
A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma | Cancer Cell International | Full Text

SAC3D1: a novel prognostic marker in hepatocellular carcinoma | Scientific  Reports
SAC3D1: a novel prognostic marker in hepatocellular carcinoma | Scientific Reports

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor  heterogeneity of HBV-associated hepatocellular carcinoma | Nature  Communications
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma | Nature Communications

The immune microenvironment and progression of immunotherapy and  combination therapeutic strategies for hepatocellular carcinoma
The immune microenvironment and progression of immunotherapy and combination therapeutic strategies for hepatocellular carcinoma

Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9  Accelerator - Gastroenterology
Cancer Gene Discovery in Hepatocellular Carcinoma: The CRISPR/CAS9 Accelerator - Gastroenterology

Advances in immunotherapy for hepatocellular carcinoma | Nature Reviews  Gastroenterology & Hepatology
Advances in immunotherapy for hepatocellular carcinoma | Nature Reviews Gastroenterology & Hepatology

Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... |  Download Scientific Diagram
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram

Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane  anchoring and MAPK pathway activation - ScienceDirect
Peptide SMIM30 promotes HCC development by inducing SRC/YES1 membrane anchoring and MAPK pathway activation - ScienceDirect

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor  heterogeneity of HBV-associated hepatocellular carcinoma | Nature  Communications
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma | Nature Communications

A new perspective on the immune escape mechanism in HCC: onco-foetal  reprogramming | British Journal of Cancer
A new perspective on the immune escape mechanism in HCC: onco-foetal reprogramming | British Journal of Cancer

Sensitivity of markers used to prove hepatocellular carcinoma (HCC)... |  Download Scientific Diagram
Sensitivity of markers used to prove hepatocellular carcinoma (HCC)... | Download Scientific Diagram

Liver Cancer Tumor Markers | GeneTex
Liver Cancer Tumor Markers | GeneTex

EGFR activation limits the response of liver cancer to lenvatinib | Nature
EGFR activation limits the response of liver cancer to lenvatinib | Nature

Global immune characterization of HBV/HCV-related hepatocellular carcinoma  identifies macrophage and T-cell subsets associated with disease  progression | Cell Discovery
Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression | Cell Discovery

EGFR activation limits the response of liver cancer to lenvatinib | Nature
EGFR activation limits the response of liver cancer to lenvatinib | Nature

Gal-1 is a CAF marker and is correlated with the poor prognosis of... |  Download Scientific Diagram
Gal-1 is a CAF marker and is correlated with the poor prognosis of... | Download Scientific Diagram

Tumor Markers and Hepatocellular Carcinoma
Tumor Markers and Hepatocellular Carcinoma

epiLiver a novel tumor specific, high throughput and cost-effective blood  test for specific detection of liver cancer (HCC) | medRxiv
epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC) | medRxiv

Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment  Response Assessment
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment

SciELO - Brasil - CircRNA has_circ_0001806 promotes hepatocellular  carcinoma progression via the miR-193a-5p/MMP16 pathway CircRNA  has_circ_0001806 promotes hepatocellular carcinoma progression via the  miR-193a-5p/MMP16 pathway
SciELO - Brasil - CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway

Cezanne predicts progression and adjuvant TACE response in hepatocellular  carcinoma | Cell Death & Disease
Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma | Cell Death & Disease

Identification of Liver Cancer Progenitors Whose Malignant Progression  Depends on Autocrine IL-6 Signaling: Cell
Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling: Cell